RFQ 36C25722Q0049.pdf

PDF 913 KB Posted Nov 3, 2021

Attached to: 6505--NTX Blood & Blood Products
Solicitation number: 36C25722Q0049
Issued by: Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17

View the file

Other files

File	Type	Posted
36C25722Q0049 0001_1.docx	DOCX document	Nov 23, 2021
36C25722Q0049 0001.pdf	PDF	Nov 23, 2021
36C25722Q0049_1.docx	DOCX document	Nov 3, 2021

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. DUNS: DUNS+4:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. 2/2012)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS 61

36C25722Q0049 11-03-2021

Delphia Schoenfeld 210-694-6336 12-03-2021

15:00

Department of Veterans Affairs

VISN17 Network Contracting Activity

5441 Babcock Road Ste. 302

San Antonio TX 78240

621991

$35 Million

N/A

VA North Texas Healthcare System

Laboratory

4500 S. Lancaster Rd.

Dallas TX 75216

VISN17 Network Contracting Activity

5441 Babcock Road Ste. 302

San Antonio TX 78240

This is accomplished through the

Tungsten Network located at:

http://www.fsc.va.gov/einvoice.asp

This is mandatory and the sole method for submitting invoices.

(877) 353-9791 (512) 460-5540

See CONTINUATION Page

This soliciation is for the purchase of blood and blood products for the VA North Texas Healthcare System.

The Government intends to award a Firm Fixed-Price, single award IDIQ to a responsible vendor that is capable of providing the required supplies and services at a fair and reasonable price.

All questions concerning this solicitation are to be submitted in writing prior to 11/19/2021, 1:00 PM Eastern

Time to Delphia Schoenfeld at delphia.schoenfeld@va.gov.

See Section B for Statement of Work and Price/Cost Schedule.

See CONTINUATION Page

X X

X 1

Michael J. Tusinger

36C25722Q0049

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 STATEMENT OF WORK

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

B.3 DELIVERY SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.2 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE

ORDERS—COMMERCIAL ITEMS (JAN 2021) (JUL 2020) (DEVIATION)

C.3 52.216-18 ORDERING (AUG 2020)

C.4 52.216-19 ORDER LIMITATIONS (OCT 1995)

C.5 52.216-22 INDEFINITE QUANTITY (OCT 1995)

C.6 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

C.7 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS (OCT

2021) (DEVIATION)

C.8 VAAR 852.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018)

C.9 VAAR 852.212-70 PROVISIONS AND CLAUSES APPLICABLE TO VA ACQUISITION OF COMMERCIAL

ITEMS (APR 2020)

C.10 VAAR 852.212-71 GRAY MARKET ITEMS (APR 2020)

C.11 VAAR 852.219-71 VA MENTOR-PROTÉGÉ PROGRAM (DEC 2009)

C.12 VAAR 852.219-72 EVALUATION FACTOR FOR PARTICIPATION IN THE VA MENTOR-PROTÉGÉ

PROGRAM (DEC 2009)

C.13 VAAR 852.219-75 SUBCONTRACTING COMMITMENTS MONITORING AND COMPLIANCE (JUL 2018)

C.14 VAAR 852.219-76 SUBCONTRACTING PLANS MONITORING AND COMPLIANCE (JUL 2018)

C.15 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)

C.16 VAAR 852.247-73 PACKING FOR DOMESTIC SHIPMENT (OCT 2018)

C.17 MANDATORY WRITTEN DISCLOSURES

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)

E.2 INSTRUCTIONS TO OFFERORS

E.3 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO

SURVEILLANCE SERVICES OR EQUIPMENT (OCT 2020)

E.4 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.5 52.212-2 EVALUATION—COMMERCIAL ITEMS (OCT 2014)

E.6 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL ITEMS (FEB 2021) (JUL

2020) (DEVIATION)

E.7 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.8 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C257

VISN17 Network Contracting Activity 5441 Babcock Road Ste. 302 San Antonio TX 78240

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or [] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] Monthly

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

This is accomplished through the Tungsten Network located at:

http://www.fsc.va.gov/einvoice.asp This is mandatory and the sole method for submitting invoices.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

B.2 STATEMENT OF WORK

The purpose of this contract is to provide safe, quality blood products to, and therapeutic phlebotomies for, Veteran patients. Pricing includes all labor, materials, equipment and supplies necessary to provide the products or perform the services.

GROUP I - WEEKLY ESTIMATED DELIVERY REQUIREMENTS:

Quantities listed are estimated weekly totals:

Item ABO/RH Type Product Type HCPCS Code Est. Weekly Qty (Unit)

1. Red Blood Cells, Leuko- Reduced (LRBC)

O pos LRBC P9016 30

O neg LRBC P9016 10

A pos LRBC P9016 30

A neg LRBC P9016 10

B pos LRBC P9016 10

B neg LRBC P9016 5

AB pos LRBC P9016 0

2. Platelets-Apheresis, Leuko-Reduced (LPPLT)

O Pos or O Neg LPPLT P9035 6

A Pos or A Neg LPPLT P9035 4

Estimated quantities shown below are for annual requirements.

GROUP II – ESTIMATED YEARLY REQUIREMENTS:

Item Product Type HCPCS Code Est. Yearly Qty (Unit)

3 Fresh frozen plasma, or Plasma frozen <24 hours (FFP or PF24) P9017 or P9059 350

4 Cryoprecipitate, frozen pooled from 5 donors (PCRYO) P9012x5 150

5 Platelet-pheresis, HLA matched P9035 5

6 Deglycerolyzed Red cells P9054 5

GROUP III – SERVICES (ESTIMATED) TO BE PROVIDED ANNUALLY:

Item Test Name CPT Codes Est. Yearly Test Volume

7 HLA Computer match fee 86828 10

8 Freezing of Patient RBC NA 5

9 Deglycerolization of frozen RBC NA 5

10 Directed Donor Fee NA 5

11 Autologous Donor Fee 86890 5

12 Irradiation Fee 86945 700

13 Platelet Crossmatch 86023 5

14 Platelet Antibody Screen 86022 3

15 Red Blood Cells Washed NA 3

16 Antigen Screen, Tier 1 antigen (C, c, E, or K) 86905 30

17 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) 86905 50

18 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence)

86905 50

19 ABO/Rh type 86900 & 86901 10

20 CMV/Sickle Screen 86644 5

21 Antibody Workup 86870 10

22 Frozen Blood Storage (up to 90 days) NA 3

23 Imported Rare Unit Fee NA 4

24 Molecular Phenotyping 81403 10

25 Therapeutic Phlebotomy Donation 99195 70

26 Therapeutic Phlebotomy Donation eligible for recipients NA 60

*Assuming continued trend in usage of blood and blood products accounting for 3.0% increase per year over the next five years.

WORK STATEMENT

1. Contractor shall furnish human blood products and services FOB Destination to the VA North Texas Health

Care System, 4500 S. Lancaster Road, Dallas, TX 75216 during the period of performance.

2. Period of Performance:

Pricing Period 1 12 Months March 2, 2022 through March 1, 2023 Pricing Period 2 12 Months March 2, 2023 through March 1, 2024 Pricing Period 3 12 Months March 2, 2024 through March 1, 2025 Pricing Period 4 12 Months March 2, 2025 through March 1, 2026 Pricing Period 5 12 Months March 2, 2026 through March 1, 2027 Option Period 1 6 Months March 2, 2027 through September 1, 2027

3. Prompt written notification shall be made by the Contractor to the VA North Texas Health Care System (VANTHCS) Transfusion Medicine Unit personnel of autologous and directed blood donations drawn on the Contractor's premises not passing all required testing.

4. Donor Requirements:

a. The Contractor shall comply with standard donor record keeping procedures on all delivered components and maintain such records according to AABB and Food and Drug Administration (FDA) guidelines. There is no requirement to exchange such information with VANTHCS under this contract.

b. Donor selection must be in accordance with criteria established by the FDA and AABB.

5. Blood Requirements:

a. All blood products must meet AABB and FDA standards.

b. All blood supplied will be free of gross hemolysis, excessive lipemia and clots.

c. Requests for fresh frozen plasma must be filled by fresh frozen plasma or plasma, frozen less than 24 hours. Frozen Plasma, Cryoreduced will not be acceptable alternatives unless requested by the VANTHCS.

d. Cryoprecipitate must be frozen in pools of 5 donors. Single random donor cryoprecipitate units will not be acceptable alternatives unless requested or authorized by the VANTHCS TMU personnel.

e. Paid donors shall not be used for furnishing blood products under this contract. "Paid" as used this specification means receipt of any compensation by the donor that violates AABB or FDA guidelines for voluntary donation.

6. Only blood suppliers and blood bank reference laboratories that are fully licensed/accredited by CLIA, AABB, and FDA and be actively engaged in providing the specific blood products and services outlined in this solicitation will be considered.

7. Contractor will supply all labor, equipment, and materials required to perform procedures/services as stated herein.

8. VANTHCS TMU personnel will place orders by telephone, online, or fax for quantities and items as needed.

VANTHCS TMU personnel will order special order items by FAX correspondence. The TMU personnel will state the time required for delivery. Multiple deliveries may be required in the same day.

9. Contractor’s distribution location should be local to VANTHCS, Dallas facility (within 50 miles) to meet stat, urgent, or emergency blood product requests.

10. All blood products shall be packed according to AABB and FDA requirements. The Contractor will furnish appropriate containers for shipment of blood products at the Contractor's expense and deliver products to VANTHCS at no charge. Empty containers and equipment will be returned at the Contractor's expense.

11. Unused red blood cell products shipped with less than 5 days remaining and unused platelet products with less than 24-hour expiration time may be returned/claimed for full credit at Contractor’s expense. All frozen products discovered broken during thawing may be claimed for full credit.

12. The contractor shall provide Therapeutic Phlebotomy Donation Services for treatment of eligible Veterans and other eligible beneficiaries from Monday through Friday at multiple locations throughout North Texas area to make access to health care easier. Donations eligible for recipients shall be provided at no charge.

13. The Contractor must provide the VANTHCS with consultation services under the direction of a physician who is qualified in Blood Banking/Transfusion Medicine. The reference laboratory must be available 24 hours a day, including weekends and holidays at no additional expense beyond the regular reference laboratory fees. The reference laboratory must meet proficiency and competency requirements as set forth by AABB and FDA.

14. The Contractor must provide VANTHCS a contingency plan to ensure adequate and safe blood supply. The Contractor’s plan should include the means for maintaining VANTHCS’ minimum inventory, requirements for notification when a donor or components are found to be seropositive, and redistribution of components for disaster or emergency need, which could include obtaining needed components by drawing donors or by agreement with another facility.

15. The Contractor recognizes that the services under this contract are vital to the Government and must be continued without interruption and that, upon contract expiration, a successor, either the Government or Contractor, may continue them.

16. Security Requirements: VA Protected Health Information is provided to the vendor under this contract. This contract is to enable a HIPAA Covered Entity to provide clinical services on behalf of VA. The patient’s consent is not required (1605.1P24). The vendor is required to secure the PHI as required by HIPAA. The C&A requirements do not apply, and a Security Accreditation Package is not required.

SECTION B REQUIREMENTS/SPECIFICATIONS:

1. Contractor shall furnish human blood products and services FOB Destination to the VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216 in such quantities and at such times as may be required for the period March 2, 2022 (or date of award if later) through March 1, 2023 (1 year base period); in accordance with the terms and conditions listed herein.

2. VANTHCS TMU personnel will place orders on an as needed basis via telephone, online or fax. The quantity, group and Rh of the items ordered will be specified at the time of order. Special order items/tests will be requested via fax. Multiple deliveries may be needed on the same day.

3. VA North Texas Health Care System (VANTHCS) makes no guarantee as to what volume of products or tests, if any, the contractor may receive. VANTHCS reserves the right to request additional products or services other than those listed within. If additional tests are added, either by the contractor or VANTHCS, the contractor shall provide to the methodology and ranges for results on any tests that are requested by representatives of

VANTHCS.

4. Donor Requirements:

b. Donor selection must be in accordance with criteria established by the FDA and AABB.

c. Prompt written notification shall be made by the Contractor to VANTHCS of autologous and directed blood donations drawn on the Contractor’s premises not passing all required testing.

5. Blood Requirements:

a. All blood products must meet AABB and FDA standards.

b. All blood supplied will be free of gross hemolysis, excessive lipemia and clots.

d. Paid donors shall not be used for furnishing blood produces under this contract. "Paid" as used this specification means receipt of any compensation by the donor that violates AABB or FDA guidelines for voluntary donation.

e. All red cell units supplied must be leukocytes reduced and must have at least 21 days remaining before expiration.

f. Platelet products must be Platelets, Pheresis Leukocytes Reduced and must be less than 72 hours old when delivered. Random donor platelets will not be acceptable alternatives unless requested or authorized by the VANTHCS TMU personnel.

g. Cryoprecipitate must be frozen in pools of 5 donors. Single random donor cryoprecipitate units will not be acceptable alternatives unless requested or authorized by the VANTHCS TMU personnel.

h. VANTHCS TMU personnel reserve the right to accept units with shorter dating if deemed appropriate.

i. Red blood cell units containing unexpected red cell antibodies will not be accepted.

j. Platelet products from donors on aspirin containing medications will not be accepted unless mutually agreed upon in advance.

6. Packing and Delivery:

a. Blood products shall be delivered at the time specified when the order is placed. The Contractor will furnish appropriate containers for shipment of blood products at the Contractor's expense. Empty containers and equipment will be returned at the Contractor's expense.

b. Deliveries shall be made to the VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd, Dallas, TX 75216 to the Transfusion Medicine Unit in Room 1B-306. The deliveries shall be made 24 hours a day, including holidays and weekends as requested. More than one delivery may be required in a 24-hour timeframe. The cost of delivery will be borne by the Contractor.

c. Contractor’s distribution facility should be local to the VANTHC Dallas facility (within 50 miles) to meet stat, urgent, or emergency blood product requests.

7. Credits:

a. Unused red blood cell products shipped with less than 5 days remaining may be returned/ claimed for full credit at Contractor's expense.

b. Unused platelet products with less than a 24-hour expiration time may be returned/claimed for full credit at Contractor's expense.

c. Frozen plasma units discovered broken during thawing may be claimed for full credit.

8. The contractor shall provide Therapeutic Phlebotomy Donation Services for treatment of eligible Veterans and other eligible beneficiaries from Monday through Friday at multiple locations throughout North Texas area to make access to health care easier. Donations eligible for recipients shall be provided at no charge.

9. The Contractor must provide the VANTHCS with consultation services under the direction of a physician who is qualified in Blood Banking/Transfusion Medicine.

10. Contractor shall provide laboratory services to include analysis, reporting of analytic results, and consultation regarding selection, collection, transportation and result interpretation. These procedures/tests shall be performed to the satisfaction of VA North Texas Health Care System (VANTHCS) Pathology & Laboratory Medicine Service, Chief of Staff, and the Contracting Officer’s Representative (COR).

11. The reference laboratory must be available 24 hours a day, including weekends and holidays at no additional expense beyond the regular reference laboratory fees. The reference laboratory must meet proficiency and competency requirements as set forth by AABB and FDA.

12. Upon reasonable notice to the Contractor, Contractor shall permit site visits by the VANTHCS ("Audits"). Such audits shall include the opportunity for VANTHCS to view the Contractor's staff performing the services and review documentation relating to the services, including billing and records related thereto, rendered pursuant to this Agreement. The VANTHCS also reserves the right to terminate the contract if the Contractor, during the term of the contract fails to meet an acceptable level of performance in carrying out contract requirements. The Contractor must provide VANTHCS a contingency plan to ensure adequate and safe blood supply. The Contractor’s plan should include the means for maintaining VANTHCS’ minimum inventory, requirements for notification when a donor or components are found to be seropositive, and redistribution of components for disaster or emergency need, which could include obtaining needed components by drawing donors or by agreement with another facility.

13. Contractor shall have the right to inspect VA storage facilities to assure quality control over returned blood products.

14. Services rendered will be verified by a record keeping system maintained by Pathology & Laboratory Medicine Service and Fiscal Service at VANTHCS, which assures that the VA pays for only those blood products and services requested, and only for valid patients of VANTHCS.

15. Services rendered will be verified by a record keeping system maintained by Pathology & Laboratory Medicine Service and Fiscal Service at VANTHCS, which assures that the VA pays for only those services requested, and only for valid patients of VANTHCS.

16. Health Insurance Portability and Accountability Act:

a. Contractor shall take reasonable measures to ensure patient privacy and confidentiality. The contract service providers herein agree to take all reasonable precautions to safeguard patient information from unauthorized access or modification, in both electronic and hard-copy formats. This includes not only electronic security measures such as “strong” user passwords on computer systems, but also physical barriers to prevent unauthorized use of computer work-stations; that hard copy patient files are in secured lockable areas, that files are in lockable cabinets, that the cabinets can in fact be locked, i.e., keys are available, and the locking mechanisms work properly. This precaution also includes the proper transfer of patient information via electronic means, such as faxing or system to system transmission.

b. That no patient information of any type shall be given to outside parties, agencies or organizations of any type without the expressed written consent of the patient and the VA North Texas Health Care System, and only in capacities directly related to the provision of the services contracted in this instrument.

c. That only the minimum necessary patient information is used to provide appropriate service to the correct patient.

d. Contractor requires no access to any V A information system. There will be supervised access when the contractor is physically present.

e. No VA data of any type shall be transferred from the VA.

17. The Contractor recognizes that the services under this contract are vital to the Government and must be continued without interruption and that, upon contract expiration, a successor, either the Government or another contractor, may continue them. The Contractor agrees to (1) furnish phase-in training and (2) exercise its best efforts and cooperation to affect an orderly and efficient transition to a successor.

NARA RM Language Clause to be included in contracts, as necessary:

1. Citations to pertinent laws, codes and regulations such as 44 U.S.C Chapter 21 , 29, 31 and 33; Freedom of Information Act (5 U.S.C. 552); Privacy Act (5 U.S.C. 552a); 36 CFR Part 1222 and Part 1228.

2. Contractor shall treat all deliverables under the contract as the property of the U.S. Government for which the Government Agency shall have unlimited rights to use, dispose of, or disclose such data contained therein as it determines to be in the public interest.

3. Contractor shall not create or maintain any records that are not specifically tied to or authorized by the contract using Government ‘IT’ equipment and/or Government records.

4. Contractor shall not retain, use, sell, or disseminate copies of any deliverable that contains information covered by the Privacy Act of 1974 or that which is generally protected by the Freedom of Information Act.

5. Contractor shall not create or maintain any records containing any Government Agency records that are not specifically tied to or authorized by the contract or identified in the RCS 10-1.

6. The Government Agency owns the rights to all data/records produced as part of this contract.

7. The Government Agency owns the rights to all electronic information (electronic data, electronic information systems, electronic databases, etc.) and all supporting documentation created as part of this contract. Contractor must deliver sufficient technical documentation with all data deliverables to permit the agency to use the data.

8. Contractor agrees to comply with Federal and Agency records management policies, including those policies associated with the safeguarding of records covered by the Privacy Act of 1974. These policies include the preservation of all records created or received regardless of format [paper, electronic, etc.] or mode of transmission [e-mail, fax, etc.] or state of completion [draft, final, etc.].

9. No disposition of documents will be allowed without the prior written consent of the Contracting Officer. The Agency and its contractors are responsible for preventing the alienation or unauthorized destruction of records, including all forms of mutilation. Willful and unlawful destruction, damage or alienation of Federal records is subject to the fines and penalties imposed by 18 U.S.C. 2701. Records may not be removed from the legal custody of the Agency or destroyed without regard to the provisions of the agency records schedules.

10. Contractor is required to obtain the Contracting Officer's approval prior to engaging in any contractual relationship (sub-contractor) in support of this contract requiring the disclosure of information, documentary material and/or records generated under or relating to this contract. The Contractor (and any sub-contractor) is required to abide by Government and Agency guidance for protecting sensitive and proprietary information.

VHA Supplemental Contract Requirements for Ensuring Adequate COVID-19 Safety Protocols for

Federal Contractors

1. Contractor employees who work in or travel to VHA locations must comply with the following:

a. Documentation requirements:

1) If fully vaccinated, shall show proof of vaccination

i. NOTE: Acceptable proof of vaccination includes a signed record of immunization from a health care provider or pharmacy, a copy of the COVID-19 Vaccination Record Card (CDC Form MLS- 319813_r, published on September 3, 2020), or a copy of medical records documenting the vaccination

2) If unvaccinated and granted a medical or religious exception, shall show negative COVID-19 test results dated within three calendar days prior to desired entry date. Test must be approved by the Food and Drug Administration (FDA) for emergency use or full approval. This includes tests available by a doctor’s order or an FDA approved over-the-counter test.

3) Documentation cited in this section shall be digitally or physically maintained on each contractor employee while in a VA facility and is subject to inspection prior to entry to VA facilities and after entry for spot inspections by Contracting Officer Representatives (CORs) or other hospital personnel.

4) Documentation will not be collected by the VA; contractors shall, at all times, adhere to and ensure compliance with federal laws designed to protect contractor employee health information and personally identifiable information.

2. Contractor employees are subject to daily screening for COVID-19 and may be denied entry to VA facilities if they fail to pass screening protocols. As part of the screening process contractors may be asked screening questions found on the following website: COVID-19 Screening Tool. Regularly check the website for updates.

a. Contractor employees who work away from VA locations, but who will have direct patient contact with VA patients shall self-screen utilizing the COVID-19 Screening Tool, in advance each day that they will have direct patient contact and in accordance with their person or persons who coordinate COVID-19 workplace safety efforts at covered contractor workplaces. Contractors shall, at all times, adhere to and ensure compliance with federal laws designed to protect contractor employee health information and personally identifiable information.

3. Contractor must immediately notify their COR or Contracting Officer if contract performance is jeopardized due to contractor employees being denied entry into VA Facilities.

References:

VHA Directive 6300 VA Handbook 6300.1 North Texas VA Medical Center Policy https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.va.gov%2Fcovid19screen%2F&data=04%7C01%7C%7C3b6851617d8f4970680608d98f384cf6%7Ce95f1b23abaf45ee821db7ab251ab3bf%7C0%7C0%7C637698294229564172%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=wu1OSMa8%2BPA6T8i8Pp%2FewzTuqDxSCiS8wLS%2FVqIvl7k%3D&reserved=0 https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.va.gov%2Fcovid19screen%2F&data=04%7C01%7C%7C3b6851617d8f4970680608d98f384cf6%7Ce95f1b23abaf45ee821db7ab251ab3bf%7C0%7C0%7C637698294229574131%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=AyfV8qESN1OyygTtYyd1Bsqnqf9xV6JocS7m40ohOac%3D&reserved=0

VA Directive 6500 36 CFR Part 1222.32 (b)

B.2 PRICE/COST SCHEDULE

This is a Single Award, Firm-Fixed Price, Indefinite Delivery Indefinite Quantity (IDIQ) Contract.

The guaranteed minimum award amount for this contract is $1,000.00. The maximum aggregate value of orders that can be placed under this contract is $6,750,000.00. The Government does not guarantee that it will place any orders under this contract in excess of the guaranteed minimum award amount.

Ordering Period:

POP Begin: 3/2/2022 POP End: 3/1/2027

Delivery Location – VA North Texas Healthcare System Laboratory 4500 S. Lancaster Rd.

Dallas, Texas 75216

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

0.00 UN __________________ __________________

Red Cells, Leukocyte reduced (LRBC)

HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period: 1 POP Begin: 03-02-2022 POP End: 03-01-2023

MANUFACTURER PART NUMBER (MPN): LRBC

0001AA

1,560.00 UN __________________ __________________

Red Cells, LRBC - O+

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 1 POP Begin: 03-02-2022

0001AB

520.00 UN __________________ __________________

Red Cells, LRBC - O-

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 1 POP Begin: 03-02-2022

0001AC

Red Cells, LRBC - A+

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 1 POP Begin: 03-02-2022

POP End: 03-01-2023

0001AD

Red Cells, LRBC - A-

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 1 POP Begin: 03-02-2022

0001AE

Red Cells, LRBC - B+

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 1 POP Begin: 03-02-2022

0001AF

260.00 UN __________________ __________________

Red Cells, LRBC - B-

Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period: 1 POP Begin: 03-02-2022

0001AG

Red Cells, LRBC - AB+

Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Contract Period: Base Pricing Period: 1 POP Begin: 03-02-2022

Platelets, Pheresis, Leukocyte reduced (LPPLT)

HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): LPPLT

0002AA

312.00 UN __________________ __________________

O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period: 1 POP Begin: 03-02-2022

0002AB

208.00 UN __________________ __________________

A+ or A-

Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period: 1 POP Begin: 03-02-2022 POP End: 03-01-2023

350.00 UN __________________ __________________

Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24)

HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): FFP

150.00 UN __________________ __________________

Cryoprecipitate, frozen pooled from 5 donors (PCRYO)

HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): PCRYO

5.00 UN __________________ __________________

Platelet-pheresis, HLA matched

HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): ILPPL + B3001

Deglycerolyzed Red cells

HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): LRDGL

10.00 UN __________________ __________________

HLA Computer match fee

CPT: 86828

Estimated Annual Qty: 10 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B3001

5.00 EA __________________ __________________

Freezing of Patient RBC

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B9079

Deglycerolization of frozen RBC

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B4001

Directed Donor Fee

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B9003

Autologous Donor Fee

CPT: 86890

Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B9002

700.00 EA __________________ __________________

Irradiation Fee

CPT: 86945

Estimated Annual Qty: 700 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B9006

Platelet Crossmatch

CPT: 86023

Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-01-2022 POP End: 02-28-2023

MANUFACTURER PART NUMBER (MPN): B3010

3.00 EA __________________ __________________

Platelet Antibody Screen

CPT: 86022

Estimated Annual Qty: 3 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B3006

Red Blood Cells Washed

CPT: NA

Estimated Annual Qty: 3 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): WLRC

30.00 EA __________________ __________________

Antigen Screen, Tier 1 antigen (C, c, E, or K)

CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B2081

50.00 EA __________________ __________________

Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1)

CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B2082

Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B2083

10.00 EA __________________ __________________

ABO/Rh type

CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B2001

CMV/ Sickle Screen

CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B9004

Antibody Workup

CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B5028

Frozen Blood Storage (up to 90 days)

CPT Code: NA Estimated Annual Qty: 3 Pricing Period: 1 POP Begin: 03-02-2022

POP End: 03-01-2023

MANUFACTURER PART NUMBER (MPN): B9316

4.00 EA __________________ __________________

Imported Rare Unit Fee

CPT Code: NA Estimated Annual Qty: 4 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B2067

Molecular Phenotyping

CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): B1009

70.00 EA __________________ __________________

Therapeutic Phlebotomy Donation

CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): PHLEB

60.00 EA __________________ __________________

Therapeutic Phlebotomy Donation (eligible for recipients)

CPT Code: NA Estimated Annual Qty: 60 Pricing Period: 1 POP Begin: 03-02-2022

MANUFACTURER PART NUMBER (MPN): Not applicable

HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period: 2 POP Begin: 03-02-2023 POP End: 03-01-2024

1001AA

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 2 POP Begin: 03-02-2023

1001AB

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 2

POP Begin: 03-02-2023 POP End: 03-01-2024

1001AC

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 2 POP Begin: 03-02-2023

1001AD

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 2 POP Begin: 03-02-2023

1001AE

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 2 POP Begin: 03-02-2023

1001AF

Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period: 2 POP Begin: 03-02-2023

1001AG

Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period: 2 POP Begin: 03-02-2023

HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period: 2 POP Begin: 03-02-2023

1002AA

O+ or O- Estimated Weekly Qty: 6

Estimated Annual Qty: 312 Pricing Period: 2 POP Begin: 03-02-2023 POP End: 03-01-2024

1002AB

A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period: 2 POP Begin: 03-02-2023

HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period: 2 POP Begin: 03-02-2023

HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period: 2 POP Begin: 03-02-2023

HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

CPT: 86828

Estimated Annual Qty: 10 Pricing Period: 2 POP Begin: 03-02-2023

Freezing of Patient RBC

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

Deglycerolization of frozen RBC

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

CPT: 86890

Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

CPT: 86945

Estimated Annual Qty: 700 Pricing Period: 2 POP Begin: 03-02-2023

CPT: 86023

Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

CPT: 86022

Estimated Annual Qty: 3 Pricing Period: 2 POP Begin: 03-02-2023

CPT: NA

Estimated Annual Qty: 3 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 2 POP Begin: 03-02-2023 prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period: 2 POP Begin: 03-02-2023

POP End: 03-01-2024

CPT Code: NA Estimated Annual Qty: 3 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: NA Estimated Annual Qty: 4 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period: 2 POP Begin: 03-02-2023

CPT Code: NA Estimated Annual Qty: 60 Pricing Period: 2 POP Begin: 03-02-2023

HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period: 3 POP Begin: 03-02-2024 POP End: 03-01-2025

2001AA

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 3

POP Begin: 03-02-2024 POP End: 03-01-2025

2001AB

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Contract Period: Option 2 Pricing Period: 3 POP Begin: 03-02-2024

2001AC

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 3 POP Begin: 03-02-2024

2001AD

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 3 POP Begin: 03-02-2024

2001AE

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 3 POP Begin: 03-02-2024

2001AF

Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period: 3 POP Begin: 03-02-2024

2001AG

Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period: 3 POP Begin: 03-02-2024

HCPCS Code: P9035

Estimated Annual Qty: 520 Pricing Period: 3 POP Begin: 03-02-2024 POP End: 03-01-2025

2002AA

O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period: 3 POP Begin: 03-02-2024

2002AB

A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period: 3 POP Begin: 03-02-2024

HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period: 3 POP Begin: 03-02-2024

HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period: 3 POP Begin: 03-02-2024

HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024

HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024

CPT: 86828

Estimated Annual Qty: 10 Pricing Period: 3 POP Begin: 03-02-2024

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024

CPT: NA

Estimated Annual Qty: 5 Contract Period: Option 2 POP Begin: 03-02-2024

CPT: 86890

Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024

CPT: 86945

Estimated Annual Qty: 700 Pricing Period: 3 POP Begin: 03-02-2024

CPT: 86023

Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024

POP End: 03-01-2025

CPT: 86022

Estimated Annual Qty: 3 Pricing Period: 3 POP Begin: 03-02-2024

CPT: NA

Estimated Annual Qty: 3 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 3 POP Begin: 03-02-2024 prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: 86644

Estimated Annual Qty: 5 Pricing Period: 3 POP Begin: 03-02-2024 POP End: 03-01-2025

CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: NA Estimated Annual Qty: 3 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: NA Estimated Annual Qty: 4 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period: 3 POP Begin: 03-02-2024

CPT Code: NA Estimated Annual Qty: 60 Pricing Period: 3 POP Begin: 03-02-2024

Red Cells, Leukocyte reduced (LRBC) HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period: 4 POP Begin: 03-02-2025 POP End: 03-01-2026

3001AA

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 4 POP Begin: 03-02-2025

3001AB

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 4 POP Begin: 03-02-2025

3001AC

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 4 POP Begin: 03-02-2025

3001AD

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 4 POP Begin: 03-02-2025

3001AE

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 4 POP Begin: 03-02-2025

3001AF

Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period: 4 POP Begin: 03-02-2025

3001AG

Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period: 4 POP Begin: 03-02-2025

HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period: 4 POP Begin: 03-02-2025

3002AA

O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period: 4 POP Begin: 03-02-2025

3002AB

A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period: 4 POP Begin: 03-02-2025

HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period: 4 POP Begin: 03-02-2025

HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period: 4 POP Begin: 03-02-2025

HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period: 4

POP Begin: 03-02-2025 POP End: 03-01-2026

HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT: 86828

Estimated Annual Qty: 10 Pricing Period: 4 POP Begin: 03-02-2025

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT: NA

Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT: 86890

Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT: 86945

Estimated Annual Qty: 700 Pricing Period: 4 POP Begin: 03-02-2025 POP End: 03-01-2026

CPT: 86023

Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT: 86022

Estimated Annual Qty: 3 Pricing Period: 4 POP Begin: 03-02-2025

CPT: NA

Estimated Annual Qty: 3 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 4 POP Begin: 03-02-2025 prevalence) CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period: 4 POP Begin: 03-02-2025

ABO/Rh type CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: NA Estimated Annual Qty: 3 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: NA Estimated Annual Qty: 4 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period: 4 POP Begin: 03-02-2025

CPT Code: NA Estimated Annual Qty: 60 Pricing Period: 4 POP Begin: 03-02-2025

HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period: 5 POP Begin: 03-02-2026 POP End: 03-01-2027

4001AA

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 5 POP Begin: 03-02-2026

4001AB

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 5 POP Begin: 03-02-2026

4001AC

Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period: 5 POP Begin: 03-02-2026

4001AD

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period: 5 POP Begin: 03-02-2026

4001AE

Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Contract Period: Option 4 Pricing Period: 5 POP Begin: 03-02-2026

POP End: 03-01-2027

4001AF

Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period: 5 POP Begin: 03-02-2026

4001AG

Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period: 5 POP Begin: 03-02-2026

HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period: 5 POP Begin: 03-02-2026

4002AA

O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period: 5 POP Begin: 03-02-2026

4002AB

A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period: 5 POP Begin: 03-02-2026

HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period: 5 POP Begin: 03-02-2026

HCPCS Code: P9012x5

Estimated Annual Qty: 150 Pricing Period: 5 POP Begin: 03-02-2026 POP End: 03-01-2027

HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period: 5 POP Begin: 03-02-2026

HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period: 5 POP Begin: 03-02-2026

CPT: 86828

Estimated Annual Qty: 10 Pricing Period: 5 POP Begin: 03-02-2026

CPT: NA